{"corpus_id":256184264,"paper_sha":"cfd5df1298fb4e12bae62214c8efc523ece48868","doi":"10.3390/ijms24031933","arxiv_id":null,"pmid":36768258,"pmcid":"9915342","mag_id":null,"dblp_id":null,"acl_id":null,"title":"Distribution of DC Subtypes: CD83+, DC-LAMP+, CD1a+, CD1c+, CD123+, and DC-SIGN+ in the Tumor Microenvironment of Endometrial Cancers—Correlation with Clinicopathologic Features","year":2023,"publication_date":"2023-01-18","venue":"International Journal of Molecular Sciences","journal":{"name":"International Journal of Molecular Sciences","pages":null,"volume":"24"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article"],"s2_fields_of_study":["Medicine"],"reference_count":55,"citation_count":3,"influential_citation_count":0,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Female","mj":false,"ui":"D005260"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Interleukin-3 Receptor alpha Subunit","mj":true,"ui":"D053650"},{"d":"Antigens, CD","mj":false,"ui":"D015703"},{"d":"Tumor Microenvironment","mj":false,"ui":"D059016"},{"d":"Dendritic Cells","mj":false,"ui":"D003713"},{"d":"Endometrial Neoplasms","mj":true,"qs":[{"q":"pathology","mj":false,"ui":"Q000473"}],"ui":"D016889"},{"d":"Glycoproteins","mj":false,"ui":"D006023"},{"d":"Antigens, CD1","mj":false,"ui":"D018949"},{"d":"DC-Specific ICAM-3 Grabbing Nonintegrin","mj":false,"ui":"D000099215"}],"chemicals":[{"n":"Interleukin-3 Receptor alpha Subunit","ui":"D053650","reg":"0"},{"n":"Antigens, CD","ui":"D015703","reg":"0"},{"n":"Glycoproteins","ui":"D006023","reg":"0"},{"n":"Antigens, CD1","ui":"D018949","reg":"0"},{"n":"DC-Specific ICAM-3 Grabbing Nonintegrin","ui":"D000099215","reg":"0"},{"n":"CD1C protein, human","ui":"C437944","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://www.mdpi.com/1422-0067/24/3/1933/pdf?version=1675222658","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/cfd5df1298fb4e12bae62214c8efc523ece48868","s2_open_access_license":"CCBY","s2_open_access_status":"GOLD","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Treatment options for endometrial cancer (EC) do not provide satisfactory survival improvement for advanced cases, hence the interest in novel therapies utilizing immunological regulatory mechanisms. Measures to modify the functionality of dendritic cells (DCs) found in TME are intensively investigated, given that DCs play a crucial role in inducing antitumor immunity. Samples of malignant endometrial neoplasms obtained from 94 patients were immunohistochemically stained with selected antibodies. Counts of positively identified DCs were correlated with clinical advancement and histological malignancy of cancers. The most prominent DC subtypes were immature DC-SIGN+ or CD123+. Mature CD83+ DCs were the fewest. We found a significant divergence of grade value distribution between cancers of different DCs’ CD1a+ counts. The DC-LAMP+ count was positively associated with grade. Cancers with the least DC CD1c+ or DC CD123+ had higher pT scores than ones that were more heavily infiltrated. ECs can suppress immune cells, hence the predominance of immature DCs in our samples. Associations between DC counts and clinicopathological features of EC were observed only for a few subsets, which was plausibly due to the low diversity of the obtained samples or the small group size. Predictive abilities of particular DC immune subsets within EC’s TME remain ambiguous, which calls for further research.","claims":[{"public_id":"cl_c9a7675ff4401dddd56968736307881e","status":"active","text":"A significant divergence of grade value distribution was found between endometrial cancers of different DC CD1a+ counts.","confidence":0.85,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_c9a7675ff4401dddd56968736307881e"},{"public_id":"cl_dba997ad30f2fb556605b574a14929de","status":"active","text":"Cancers with the least DC CD1c+ or DC CD123+ counts had higher pT scores than those more heavily infiltrated.","confidence":0.9,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_dba997ad30f2fb556605b574a14929de"},{"public_id":"cl_ce9f2f6b1417d1b335c032e099a98138","status":"active","text":"The DC-LAMP+ count was positively associated with histological grade in endometrial cancers.","confidence":0.9,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_ce9f2f6b1417d1b335c032e099a98138"},{"public_id":"cl_b7b917a43a90824f3ee1ee27d2e5bd50","status":"active","text":"The most prominent DC subtypes in endometrial cancer tumor microenvironment were immature DC-SIGN+ or CD123+; mature CD83+ DCs were the fewest.","confidence":0.95,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_b7b917a43a90824f3ee1ee27d2e5bd50"}],"concepts":[{"public_id":"co_0847ba108e41fe02d0d008679358d7d4","status":"active","name":"CD1c+ dendritic cells","description":"Dendritic cells expressing CD1c; cancers with the lowest counts had higher pT scores.","types":["cell subtype"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_0847ba108e41fe02d0d008679358d7d4"},{"public_id":"co_0bfd80420862481b2184f48d308afa74","status":"active","name":"CD1a+ dendritic cells","description":"Dendritic cells expressing CD1a; a significant divergence of grade value distribution was observed across different counts.","types":["cell subtype"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_0bfd80420862481b2184f48d308afa74"},{"public_id":"co_132e732254c7bfa2672fac1971a14c83","status":"active","name":"histological grade","description":"A measure of histological malignancy of endometrial cancers, used in correlation analyses with dendritic cell counts.","types":["clinicopathological feature"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_132e732254c7bfa2672fac1971a14c83"},{"public_id":"co_1473e2f30a7476add64be60395543063","status":"active","name":"DC-LAMP+ dendritic cells","description":"Dendritic cells expressing DC-LAMP, whose count was positively associated with histological grade in endometrial cancers.","types":["cell subtype"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_1473e2f30a7476add64be60395543063"},{"public_id":"co_17277bf0208a6dd8da81461c1a0fa594","status":"active","name":"CD123+ dendritic cells","description":"Immature dendritic cells expressing CD123, found to be prominent in the tumor microenvironment of endometrial cancers.","types":["cell subtype"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_17277bf0208a6dd8da81461c1a0fa594"},{"public_id":"co_43a4d62631c8dac80be47136e310d25f","status":"active","name":"CD83+ dendritic cells","description":"Mature dendritic cells expressing CD83, reported as the fewest subtype in endometrial cancer samples.","types":["cell subtype"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_43a4d62631c8dac80be47136e310d25f"},{"public_id":"co_43c608a980dd7d2fb6b0d419a6c760fa","status":"active","name":"endometrial cancer","description":"Malignant endometrial neoplasms from which samples were obtained for immunohistochemical staining of dendritic cells.","types":["disease"],"aliases":["EC"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_43c608a980dd7d2fb6b0d419a6c760fa"},{"public_id":"co_740746d25acb96db69e33acb239010ec","status":"active","name":"pT score","description":"Pathological tumor stage score for endometrial cancers, higher in cancers with lower CD1c+ or CD123+ dendritic cell counts.","types":["clinicopathological feature"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_740746d25acb96db69e33acb239010ec"},{"public_id":"co_84411a994873f6db2459a8cd01f74748","status":"active","name":"tumor microenvironment","description":"The cellular environment of endometrial cancers in which dendritic cell subtypes were analyzed.","types":["biological context"],"aliases":["TME"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_84411a994873f6db2459a8cd01f74748"},{"public_id":"co_a05c516beb5842b8921d22d77c1fb6cb","status":"active","name":"DC-SIGN+ dendritic cells","description":"Immature dendritic cells expressing DC-SIGN, found to be prominent in the tumor microenvironment of endometrial cancers.","types":["cell subtype"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_a05c516beb5842b8921d22d77c1fb6cb"}],"external_ids":{"DOI":"10.3390/ijms24031933","ArXiv":null,"PubMed":36768258,"PubMedCentral":"9915342","MAG":null,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://www.mdpi.com/1422-0067/24/3/1933/pdf?version=1675222658","landing_url":"https://www.semanticscholar.org/paper/cfd5df1298fb4e12bae62214c8efc523ece48868","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBY","status":"GOLD","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":637928,"paper_uid":"7d05a9b9-ee5a-4dc5-bdc8-30d623b427b7","canonical_identity":{"paper_id":637928,"paper_uid":"7d05a9b9-ee5a-4dc5-bdc8-30d623b427b7","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/256184264"}